Hanaa Tashkandi

634 total citations
21 papers, 200 citations indexed

About

Hanaa Tashkandi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Hanaa Tashkandi has authored 21 papers receiving a total of 200 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Hanaa Tashkandi's work include Chemotherapy-induced organ toxicity mitigation (3 papers), Synthesis and biological activity (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Hanaa Tashkandi is often cited by papers focused on Chemotherapy-induced organ toxicity mitigation (3 papers), Synthesis and biological activity (2 papers) and PI3K/AKT/mTOR signaling in cancer (2 papers). Hanaa Tashkandi collaborates with scholars based in Saudi Arabia, Egypt and India. Hanaa Tashkandi's co-authors include Steve Harakeh, Shafiul Haque, Soad K. Al Jaouni, Mervat M. Omran, Soad Shaker Ali, Nagla A. El‐Shitany, Rajaa Al‐Raddadi, Heba F. Salem, Mohammed Qari and Shaker A. Mousa and has published in prestigious journals such as Renewable and Sustainable Energy Reviews, International Journal of Molecular Sciences and BMC Genomics.

In The Last Decade

Hanaa Tashkandi

19 papers receiving 194 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hanaa Tashkandi Saudi Arabia 8 62 53 30 26 23 21 200
Ananya Dutta India 12 25 0.4× 74 1.4× 26 0.9× 16 0.6× 28 1.2× 27 313
Gabriel Gontijo Brazil 7 31 0.5× 79 1.5× 27 0.9× 13 0.5× 35 1.5× 12 472
Bohumil Zálešák Czechia 12 55 0.9× 78 1.5× 40 1.3× 26 1.0× 25 1.1× 24 339
Martina Placidi Italy 8 39 0.6× 70 1.3× 49 1.6× 10 0.4× 33 1.4× 17 311
Metka Adamič Slovenia 7 35 0.6× 54 1.0× 11 0.4× 19 0.7× 25 1.1× 13 389
Gabriela Ciavoi Romania 9 18 0.3× 73 1.4× 18 0.6× 11 0.4× 41 1.8× 50 311
Mahboobeh Mehrabani Natanzi Iran 10 54 0.9× 87 1.6× 36 1.2× 26 1.0× 58 2.5× 24 335
Eman A. Mazyed Egypt 10 26 0.4× 72 1.4× 12 0.4× 21 0.8× 47 2.0× 18 362
Fatemeh Beyranvand Iran 10 19 0.3× 83 1.6× 38 1.3× 21 0.8× 38 1.7× 17 316
Ioana Scrobotă Romania 8 14 0.2× 58 1.1× 18 0.6× 13 0.5× 29 1.3× 27 248

Countries citing papers authored by Hanaa Tashkandi

Since Specialization
Citations

This map shows the geographic impact of Hanaa Tashkandi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hanaa Tashkandi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hanaa Tashkandi more than expected).

Fields of papers citing papers by Hanaa Tashkandi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hanaa Tashkandi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hanaa Tashkandi. The network helps show where Hanaa Tashkandi may publish in the future.

Co-authorship network of co-authors of Hanaa Tashkandi

This figure shows the co-authorship network connecting the top 25 collaborators of Hanaa Tashkandi. A scholar is included among the top collaborators of Hanaa Tashkandi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hanaa Tashkandi. Hanaa Tashkandi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Harakeh, Steve, Rajaa Al‐Raddadi, Soad K. Al Jaouni, et al.. (2023). Apoptosis induction in human hepatoma cell line HepG2 cells by trans- Anethole via activation of mitochondria-mediated apoptotic pathways. Biomedicine & Pharmacotherapy. 165. 115236–115236. 11 indexed citations
2.
Mahmoud, Maged Mostafa, Hanaa Tashkandi, Shafiul Haque, et al.. (2023). Combinatorial Network of Transcriptional and miRNA Regulation in Colorectal Cancer. International Journal of Molecular Sciences. 24(6). 5356–5356. 1 indexed citations
3.
Harakeh, Steve, Saber H. Saber, Rajaa Al‐Raddadi, et al.. (2023). Novel 3′-diindolylmethane nanoformulation induces apoptosis, and reduces migration and angiogenesis in liver cancer cells. Journal of King Saud University - Science. 35(8). 102864–102864. 2 indexed citations
4.
Tashkandi, Hanaa, et al.. (2023). Vinpocetine mitigates methotrexate-induced duodenal intoxication by modulating NF-κB, JAK1/STAT-3, and RIPK1/RIPK3/MLKL signals. Immunopharmacology and Immunotoxicology. 46(1). 11–19. 6 indexed citations
5.
Singh, Tripti, Rajeev Singh, Shalini Sharma, et al.. (2023). Algal biohydrogen production: Impact of biodiversity and nanomaterials induction. Renewable and Sustainable Energy Reviews. 183. 113389–113389. 13 indexed citations
6.
7.
Singh, Atamjit, Kirandeep Kaur, Ajay Kumar, et al.. (2023). 4-methylthiobutyl isothiocyanate synergize the antiproliferative and pro-apoptotic effects of paclitaxel in human breast cancer cells. Biotechnology and Genetic Engineering Reviews. 40(4). 3780–3804. 4 indexed citations
8.
Dhasmana, Archna, Sumira Malik, Anuj Ranjan, et al.. (2022). A Bioengineered Quercetin-Loaded 3D Bio-Polymeric Graft for Tissue Regeneration and Repair. Biomedicines. 10(12). 3157–3157. 4 indexed citations
9.
Khatoon, Fatima, Shafiul Haque, Anwar M. Hashem, et al.. (2022). Network-based approach for targeting human kinases commonly associated with amyotrophic lateral sclerosis and cancer. Frontiers in Molecular Neuroscience. 15. 1023286–1023286.
10.
Salem, Heba F., et al.. (2022). Efficacy of Metformin as Adjuvant Therapy in Metastatic Breast Cancer Treatment. Journal of Clinical Medicine. 11(19). 5505–5505. 16 indexed citations
11.
Tashkandi, Hanaa. (2021). Honey in wound healing: An updated review. Open Life Sciences. 16(1). 1091–1100. 85 indexed citations
12.
Harakeh, Steve, Mohammed Qari, Soad Shaker Ali, et al.. (2021). Ellagic acid nanoparticles attenuate oxidative stress and testicular damage in high fat Diet/Streptozotocin-Induced diabetic rats. Journal of King Saud University - Science. 34(2). 101720–101720. 11 indexed citations
13.
Haq, Farhan, Salmaan Sharif, Adnan Khurshid, et al.. (2020). Reverse transcriptase loop-mediated isothermal amplification (RT-LAMP)-based diagnosis: A potential alternative to quantitative real-time PCR based detection of the novel SARS-COV-2 virus. Saudi Journal of Biological Sciences. 28(1). 942–947. 11 indexed citations
14.
Al‐Ghafari, Ayat B., Huda A. Al Doghaither, Ekramy Elmorsy, et al.. (2020). Association between <em>MDR1</em> polymorphisms and XELIRI and XELOX chemoresistance in Saudi patients with colorectal cancer. Oncology Letters. 20(5). 1–1. 2 indexed citations
15.
Tashkandi, Hanaa, et al.. (2020). Impact of breast cancer treatments on body image and quality of life in survivors. International Journal of Medicine in Developing Countries. 635–644. 7 indexed citations
16.
Altaf, Abdulmalik, et al.. (2019). Patients' attitudes and knowledge toward clinical trial participation. 7(2). 69. 1 indexed citations
17.
Altaf, Abdulmalik, et al.. (2019). Patients' attitudes and knowledge toward clinical trial participation. 7(2). 69–69. 5 indexed citations
18.
Altaf, Abdulmalik, et al.. (2019). Predictors of career satisfaction among physicians: Observations from a tertiary care center. 7(3). 87–87. 1 indexed citations
19.
20.
Merdad, Adnan, Jaudah Al‐Maghrabi, Mamdooh Gari, et al.. (2014). Detection of rare single nucleotide variants affecting genes in the DNA repair pathways in hereditary breast cancer. BMC Genomics. 15(S2). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ananya Dutta Breakdown of academic impact, for papers by Gabriel Gontijo Breakdown of academic impact, for papers by Bohumil Zálešák Breakdown of academic impact, for papers by Martina Placidi Breakdown of academic impact, for papers by Metka Adamič Breakdown of academic impact, for papers by Gabriela Ciavoi Breakdown of academic impact, for papers by Mahboobeh Mehrabani Natanzi Breakdown of academic impact, for papers by Eman A. Mazyed Breakdown of academic impact, for papers by Fatemeh Beyranvand Breakdown of academic impact, for papers by Ioana Scrobotă
Rankless by CCL
2026